Blend Labs (NYSE:BLND - Free Report) had its target price lowered by Keefe, Bruyette & Woods from $4.00 to $3.75 in a research report sent to investors on Friday,Benzinga reports. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
BLND has been the subject of a number of other reports. Canaccord Genuity Group restated a "buy" rating and set a $5.25 price objective on shares of Blend Labs in a research report on Monday, May 12th. Wells Fargo & Company decreased their price objective on Blend Labs from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. JMP Securities restated a "market outperform" rating and set a $7.00 price objective on shares of Blend Labs in a research report on Wednesday, May 28th. Finally, The Goldman Sachs Group cut their price target on Blend Labs from $5.60 to $4.80 and set a "buy" rating for the company in a research note on Monday, May 12th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $4.88.
Get Our Latest Stock Report on Blend Labs
Blend Labs Stock Performance
Shares of NYSE:BLND traded up $0.09 on Friday, hitting $3.02. The company's stock had a trading volume of 245,962 shares, compared to its average volume of 2,833,613. Blend Labs has a 12 month low of $2.63 and a 12 month high of $5.53. The company has a market capitalization of $782.87 million, a price-to-earnings ratio of -19.97 and a beta of 1.24. The stock's 50-day moving average is $3.43 and its two-hundred day moving average is $3.47.
Blend Labs (NYSE:BLND - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.05). The company had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Equities analysts expect that Blend Labs will post -0.19 earnings per share for the current fiscal year.
Insider Activity at Blend Labs
In other Blend Labs news, insider Nima Ghamsari sold 75,720 shares of Blend Labs stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $3.30, for a total value of $249,876.00. Following the transaction, the insider directly owned 6,065,937 shares of the company's stock, valued at $20,017,592.10. The trade was a 1.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $3.63, for a total value of $90,750.00. Following the completion of the transaction, the insider directly owned 721,598 shares in the company, valued at approximately $2,619,400.74. This represents a 3.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 224,850 shares of company stock worth $763,164. Company insiders own 35.52% of the company's stock.
Institutional Trading of Blend Labs
Several institutional investors have recently modified their holdings of the company. Merit Financial Group LLC acquired a new stake in Blend Labs in the 1st quarter valued at $36,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Blend Labs in the second quarter worth $37,000. Quadrature Capital Ltd acquired a new position in Blend Labs in the second quarter worth $40,000. Truist Financial Corp acquired a new position in Blend Labs in the second quarter worth $41,000. Finally, Crescent Park Management L.P. acquired a new position in Blend Labs in the first quarter worth $43,000. Institutional investors and hedge funds own 52.56% of the company's stock.
Blend Labs Company Profile
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Recommended Stories

Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.